Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant TIGIT (Vibostolimab Biosimilar) antibody

Reactivity: Human ELISA, FACS, BLI, Func, SPR Host: Human Monoclonal unconjugated Recombinant Antibody
Catalog No. ABIN7581705
  • Target See all TIGIT (Vibostolimab Biosimilar) products
    TIGIT (Vibostolimab Biosimilar)
    Antibody Type
    Recombinant Antibody
    Reactivity
    Human
    Host
    • 1
    • 1
    Human
    Expression System
    CHO Cells
    Clonality
    • 2
    Monoclonal
    Conjugate
    • 2
    This TIGIT (Vibostolimab Biosimilar) antibody is un-conjugated
    Application
    ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
    Purpose
    Anti-TIGIT Reference Antibody (vibostolimab)
    Sequence
    EVQLVQSGAE VKKPGSSVKV SCKASGYTFS SYVMHWVRQA PGQGLEWIGY IDPYNDGAKY AQKFQGRVTL TSDKSTSTAY MELSSLRSED TAVYYCARGG PYGWYFDVWG QGTTVTVSSA STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSRDEL TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ QGNVFSCSVM HEALHNHYTQ KSLSLSPGK,DIQMTQSPSS LSASVGDRVT ITCRASEHIY SYLSWYQQKP GKVPKLLIYN AKTLAEGVPS RFSGSGSGTD FTLTISSLQP EDVATYYCQH HFGSPLTFGQ GTRLEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
    Characteristics
    Anti-TIGIT Reference Antibody (vibostolimab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
    Purity
    >95 %
    Isotype
    IgG1
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Comment

    Therapeutic Agents by Target and Mechanism: TIGIT inhibitors

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Concentration
    1 mg/mL
    Buffer
    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
    Storage
    4 °C,-80 °C
    Storage Comment
    +4°C,-80°C
  • Target
    TIGIT (Vibostolimab Biosimilar)
    Abstract
    TIGIT (Vibostolimab Biosimilar) Products
    Target Type
    Biosimilar
    Molecular Weight
    145.5 kDa
    UniProt
    Q495A1
You are here:
Support